Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 12 08 2019
pubmed: 17 11 2019
medline: 25 11 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

The aim of this work is to evaluate pattern of care and clinical outcome in a large series of patients with in-breast recurrence (IBR), after quadrantectomy and intraoperative radiation therapy with electrons (IOERT) as partial breast irradiation. Patients with IBR after IOERT, treated with salvage surgery ± adjuvant reirradiation (re-RT), were selected from a multiinstitution database. Disease-free survival (DFS), overall survival (OS), cumulative incidence of second IBR, and distant metastases (DM) were estimated. A total of 224/267 patients from seven institutions were included. Primary tumors received 21 Gy. Median time to first IBR was 4.3 years (range 2.6-6.1 years). Salvage mastectomy and repeat quadrantectomy were performed in 135 (60.3%) and 89 (39.7%) patients, followed by adjuvant re-RT in 21/135 (15.5%) and 63/89 (70.8%), respectively. Median follow-up after salvage treatment was 4.1 years. Overall, 5- and 8-year outcomes were as follows: cumulative incidence of second IBR: 8.4% and 14.8%; cumulative incidence of DM: 17.1% and 22.5%; DFS: 67.4% and 52.5%; OS: 89.3% and 74.7%. The risk of second IBR was similar in the salvage mastectomy and repeat quadrantectomy + RT groups [hazard ratio (HR) 1.41, p = 0.566], while salvage mastectomy patients had greater risk of DM (HR 3.15, p = 0.019), as well as poorer DFS (HR 2.13, p = 0.016) and a trend towards worse OS (HR 3.27, p = 0.059). Patients who underwent repeat quadrantectomy alone had worse outcomes (second IBR, HR 5.63, p = 0.006; DFS, HR 3.21, p = 0.003; OS, HR 4.38, p = 0.044) than those adding re-RT. Repeat quadrantectomy + RT represents an effective salvage approach and achieved local control comparable to that of salvage mastectomy.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this work is to evaluate pattern of care and clinical outcome in a large series of patients with in-breast recurrence (IBR), after quadrantectomy and intraoperative radiation therapy with electrons (IOERT) as partial breast irradiation.
PATIENTS AND METHODS METHODS
Patients with IBR after IOERT, treated with salvage surgery ± adjuvant reirradiation (re-RT), were selected from a multiinstitution database. Disease-free survival (DFS), overall survival (OS), cumulative incidence of second IBR, and distant metastases (DM) were estimated.
RESULTS RESULTS
A total of 224/267 patients from seven institutions were included. Primary tumors received 21 Gy. Median time to first IBR was 4.3 years (range 2.6-6.1 years). Salvage mastectomy and repeat quadrantectomy were performed in 135 (60.3%) and 89 (39.7%) patients, followed by adjuvant re-RT in 21/135 (15.5%) and 63/89 (70.8%), respectively. Median follow-up after salvage treatment was 4.1 years. Overall, 5- and 8-year outcomes were as follows: cumulative incidence of second IBR: 8.4% and 14.8%; cumulative incidence of DM: 17.1% and 22.5%; DFS: 67.4% and 52.5%; OS: 89.3% and 74.7%. The risk of second IBR was similar in the salvage mastectomy and repeat quadrantectomy + RT groups [hazard ratio (HR) 1.41, p = 0.566], while salvage mastectomy patients had greater risk of DM (HR 3.15, p = 0.019), as well as poorer DFS (HR 2.13, p = 0.016) and a trend towards worse OS (HR 3.27, p = 0.059). Patients who underwent repeat quadrantectomy alone had worse outcomes (second IBR, HR 5.63, p = 0.006; DFS, HR 3.21, p = 0.003; OS, HR 4.38, p = 0.044) than those adding re-RT.
CONCLUSIONS CONCLUSIONS
Repeat quadrantectomy + RT represents an effective salvage approach and achieved local control comparable to that of salvage mastectomy.

Identifiants

pubmed: 31732946
doi: 10.1245/s10434-019-08075-3
pii: 10.1245/s10434-019-08075-3
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

752-762

Auteurs

Maria Cristina Leonardi (MC)

Division of Radiation Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy. cristina.leonardi@ieo.it.

Luigi Tomio (L)

Radiotherapy Unit, Santa Chiara Hospital, Trento, Italy. ltomio@yahoo.it.

Davide Radice (D)

Division of Epidemiology and Biostatistics, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Silvia Takanen (S)

Radiotherapy Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy.

Elisabetta Bonzano (E)

Department of Radiation Oncology, IRCCS Policlinico San Martino and University, Genoa, Italy.

Marina Alessandro (M)

Radiotherapy Division, Città di Castello Hospital, Città di Castello, Italy.

Antonella Ciabattoni (A)

Department of Radiotherapy, San Filippo Neri Hospital, Rome, Italy.

Giovanni Battista Ivaldi (GB)

Department of Radiotherapy, Istituti Clinici Scientifici Maugeri¸IRCCS, Pavia, Italy.

Vincenzo Bagnardi (V)

Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.

Ombretta Alessandro (O)

Division of Radiation Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.

Claudia Maria Francia (CM)

Division of Radiation Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Cristiana Fodor (C)

Division of Radiation Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Eleonora Miglietta (E)

Division of Radiation Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Paolo Veronesi (P)

Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
Division of Breast Surgery, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Viviana Enrica Galimberti (VE)

Division of Breast Surgery, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Roberto Orecchia (R)

Scientific Directorate, European Institute of Oncology, IEO, IRCCS, Milan, Italy.

Luca Tagliaferri (L)

UOC Radioterapia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Cristiana Vidali (C)

Department of Radiotherapy, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy.

Mariangela Massaccesi (M)

UOC Radioterapia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Marina Guenzi (M)

Department of Radiation Oncology, IRCCS Policlinico San Martino and University, Genoa, Italy.

Barbara Alicja Jereczek-Fossa (BA)

Division of Radiation Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy.
Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH